These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 15285718)

  • 41. The rat insulin-degrading enzyme. Molecular cloning and characterization of tissue-specific transcripts.
    Baumeister H; Müller D; Rehbein M; Richter D
    FEBS Lett; 1993 Feb; 317(3):250-4. PubMed ID: 8425612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme.
    Kurochkin IV
    FEBS Lett; 1998 May; 427(2):153-6. PubMed ID: 9607302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin-Degrading Enzyme: Paradoxes and Possibilities.
    Leissring MA
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Choice of a start codon in a single transcript determines DNA ligase 1 isoform production and intracellular targeting in Arabidopsis thaliana.
    Sunderland PA; West CE; Waterworth WM; Bray CM
    Biochem Soc Trans; 2004 Aug; 32(Pt 4):614-6. PubMed ID: 15270689
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin.
    Leissring MA; Malito E; Hedouin S; Reinstatler L; Sahara T; Abdul-Hay SO; Choudhry S; Maharvi GM; Fauq AH; Huzarska M; May PS; Choi S; Logan TP; Turk BE; Cantley LC; Manolopoulou M; Tang WJ; Stein RL; Cuny GD; Selkoe DJ
    PLoS One; 2010 May; 5(5):e10504. PubMed ID: 20498699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues.
    Kochkina EG; Plesneva SA; Vasilev DS; Zhuravin IA; Turner AJ; Nalivaeva NN
    Biogerontology; 2015 Aug; 16(4):473-84. PubMed ID: 25792373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of insulin-degrading enzyme in insulin- and atrial natriuretic peptide-sensitive internalization of amyloid-β peptide in mouse brain capillary endothelial cells.
    Ito S; Ohtsuki S; Murata S; Katsukura Y; Suzuki H; Funaki M; Tachikawa M; Terasaki T
    J Alzheimers Dis; 2014; 38(1):185-200. PubMed ID: 23948938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Partition and turnover of glutathione reductase from Saccharomyces cerevisiae: a proteomic approach.
    Couto N; Malys N; Gaskell SJ; Barber J
    J Proteome Res; 2013 Jun; 12(6):2885-94. PubMed ID: 23631642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin-degrading enzyme antagonizes insulin-dependent tissue growth and Abeta-induced neurotoxicity in Drosophila.
    Tsuda M; Kobayashi T; Matsuo T; Aigaki T
    FEBS Lett; 2010 Jul; 584(13):2916-20. PubMed ID: 20493190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin deprivation decreases insulin degrading enzyme levels in primary cultured cortical neurons and in the cerebral cortex of rats with streptozotocin-induced diabetes.
    Kazkayasi I; Burul-Bozkurt N; Ismail MA; Merino-Serrais P; Pekiner C; Cedazo-Minguez A; Uma S
    Pharmacol Rep; 2018 Aug; 70(4):677-683. PubMed ID: 29940507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High throughput gene complementation screening permits identification of a mammalian mitochondrial protein synthesis (ρ(-)) mutant.
    Potluri P; Procaccio V; Scheffler IE; Wallace DC
    Biochim Biophys Acta; 2016 Aug; 1857(8):1336-1343. PubMed ID: 26946086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The C-terminal domain of human insulin degrading enzyme is required for dimerization and substrate recognition.
    Li P; Kuo WL; Yousef M; Rosner MR; Tang WJ
    Biochem Biophys Res Commun; 2006 May; 343(4):1032-7. PubMed ID: 16574064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional relevance of a novel SlyX motif in non-conventional secretion of insulin-degrading enzyme.
    Glebov K; Schütze S; Walter J
    J Biol Chem; 2011 Jul; 286(26):22711-5. PubMed ID: 21576244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anion activation site of insulin-degrading enzyme.
    Noinaj N; Song ES; Bhasin S; Alper BJ; Schmidt WK; Hersh LB; Rodgers DW
    J Biol Chem; 2012 Jan; 287(1):48-57. PubMed ID: 22049080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CUG start codon generates thioredoxin/glutathione reductase isoforms in mouse testes.
    Gerashchenko MV; Su D; Gladyshev VN
    J Biol Chem; 2010 Feb; 285(7):4595-602. PubMed ID: 20018845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin-degrading enzyme: a link between Alzheimer's and type 2 diabetes mellitus.
    Haque R; Nazir A
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):259-64. PubMed ID: 24059320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of zinc ligands of the insulin-degrading enzyme.
    Perlman RK; Rosner MR
    J Biol Chem; 1994 Dec; 269(52):33140-5. PubMed ID: 7806544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inducible expression and cellular localization of insulin-degrading enzyme in a stably transfected cell line.
    Kuo WL; Gehm BD; Rosner MR; Li W; Keller G
    J Biol Chem; 1994 Sep; 269(36):22599-606. PubMed ID: 8077210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of insulin-degrading enzyme with a 70 kDa cytosolic protein in hepatoma cells.
    Authier F; Cameron PH; Taupin V
    Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):149-58. PubMed ID: 8870662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptional directionality of the human insulin-degrading enzyme promoter.
    Zhang L; Wang P; Ding Q; Wang Z
    Mol Cell Biochem; 2013 Oct; 382(1-2):237-42. PubMed ID: 23797320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.